Compound Evidence File
#EC-2026-0116
HCG
Filed under Peptides. The bureau holds 134 laboratory returns for this compound from 46 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
46 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 20 Jan 2026 | 8 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Nov 2025 | 11 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 24 Jan 2026 | 11 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Dec 2025 | 4 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 10.0 | 10.0 | 17 Jan 2026 | 9 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 27 Apr 2026 | 14 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Nov 2025 | 1 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 21 Jan 2026 | 9 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Jun 2026 | 26 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 10.0 | 10.0 | 10.0 | 11 Dec 2025 | 1 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 10.0 | 10.0 | 12 Dec 2025 | 2 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 14 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 10.0 | 10.0 | 24 May 2026 | 1 Aug 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 21 May 2026 | 3 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 28 Jan 2026 | 8 Mar 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 26 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Mar 2026 | 14 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 15 Mar 2026 | 24 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Apr 2026 | 14 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 20 May 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 9.9 | 9 May 2026 | 25 Jun 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 9.4 | 9.4 | 9.4 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 4 | 9.0 | 8.7 | 9.5 | 25 May 2026 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.8 | 8.2 | 9.6 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.7 | 6.6 | 9.4 | 24 May 2026 | 24 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.7 | 8.7 | 8.7 | 3 Jul 2025 | 3 Jul 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 8.2 | 8.2 | 8.2 | 28 Mar 2025 | 28 Mar 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.1 | 6.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 7.8 | 7.4 | 8.1 | 25 May 2026 | 25 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 3 | 7.4 | 7.3 | 7.7 | 2 Apr 2025 | 24 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 11 | 7.2 | 3.9 | 9.6 | 11 Jun 2025 | 19 Jan 2026 |
| LSPLCASE #VI-2026-0523 | X | 3 | 7.1 | 5.9 | 9.1 | 27 Feb 2025 | 26 Jan 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 7.1 | 7.1 | 7.1 | 3 Jul 2025 | 3 Jul 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 | 3 Jul 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 6.2 | 6.2 | 6.2 | 8 Jul 2025 | 8 Jul 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 | 13 Feb 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 | 20 Jun 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 5.7 | 3.9 | 7.4 | 27 Feb 2025 | 23 May 2026 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 | 21 May 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 4.7 | 4.7 | 4.7 | 25 Apr 2025 | 25 Apr 2025 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 4.0 | 4.0 | 4.0 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 2.8 | 2.8 | 2.8 | 17 Dec 2024 | 17 Dec 2024 |
| Biolabshop LimitedCASE #VI-2026-0832 | X | 1 | 2.5 | 2.5 | 2.5 | 27 Feb 2025 | 27 Feb 2025 |
Open any subject to view the batch-level evidence for HCG alone.